CA1293213C - Derives de cannabinol et methode de dosage immunologique amelioree
- Google Patents
Derives de cannabinol et methode de dosage immunologique amelioree
Info
Publication number
CA1293213C
CA1293213CCA000557275ACA557275ACA1293213CCA 1293213 CCA1293213 CCA 1293213CCA 000557275 ACA000557275 ACA 000557275ACA 557275 ACA557275 ACA 557275ACA 1293213 CCA1293213 CCA 1293213C
Authority
CA
Canada
Prior art keywords
cannabinol
labeled compound
derivative
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AGfiledCriticalF Hoffmann La Roche AG
Priority to CA000557275ApriorityCriticalpatent/CA1293213C/fr
Application grantedgrantedCritical
Publication of CA1293213CpublicationCriticalpatent/CA1293213C/fr